产品中心 抗体 其他一抗

所有图片(1/1)

ORAI3 Recombinant Rabbit mAb (S-2486-117)

Protein orai-3,Transmembrane protein 142C,TMEM142C

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6483
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    ORAI3
  • 分子别名

    Protein orai-3; Transmembrane protein 142C; TMEM142C
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cell membrane
  • Accession

    Q9BRQ5
  • 克隆号

    S-2486-117
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Ms
  • 阳性样本

    NIH/3T3, RAW264.7, A20
  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Ms
背景介绍
  • ORAI3 is a four-transmembrane store-operated Ca²⁺ channel protein that, upon association with the endoplasmic-reticulum Ca²⁺ sensor STIM1, forms highly Ca²⁺-selective CRAC channels mediating store-operated Ca²⁺ entry (SOCE) essential for T- and B-cell activation, endothelial and smooth-muscell function, and metabolic reprogramming; beyond SOCE, ORAI3 can heteromerize with ORAI1 to create arachidonic-acid-activated, store-independent channels, is transcriptionally up-regulated by TGF-β to drive the epithelial–mesenchymal transition gene Snai1, and in many cancers its over-expression promotes stemness, migration, chemoresistance and tumour growth via both Ca²⁺-dependent and Ca²⁺-independent signalling, making it a potential prognostic biomarker and therapeutic target.

  • 免疫印迹

    • WB result of ORAI3 Recombinant Rabbit mAb
      Primary antibody: ORAI3 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: NIH/3T3 whole cell lysate 20 µg
      Lane 2: RAW264.7 whole cell lysate 20 µg
      Lane 3: A20 whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 31 kDa
      Observed MW: 28 kDa
      This blot was developed with high sensitivity substrate

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)